Notes / Company Venus Remedies Ltd. VENUSREM BSE 526953 ISIN INE411B01019 Pharmaceuticals Fundamentals Market cap₹1,446 cr P/E18.95× ROE8.08% Debt / equity0.00 52-week range 351.10 — 1088.80 Research on Tijori Finance The timeline — 1 note on Venus Remedies Ltd. May 2026 22 May 26 · 11:56 IST Lead Lead · Regulatory Venus Remedies enters Saudi market with Plerixafor approval The company lands its first global marketing authorization for the specialty oncology injectable, targeting the Gulf's largest pharmaceutical market. Verify on exchange BSE filings for VENUSREM NSE filings for VENUSREM Tijori Finance company page